Group 1 - The core point of the news is that shareholders of Mountain Outside Mountain (688410.SH) plan to reduce their holdings by up to 12,852,625 shares, representing a maximum of 4.00% of the company's total share capital, due to their own funding needs [1] - The shareholders involved in the reduction are Hunan Xiangjiang Liyuan Investment Management Co., Ltd. - Hunan Xiangjiang Health Entrepreneurship Investment Partnership (Limited Partnership) and Hunan Xiangjiang Liyuan Investment Management Co., Ltd. - Hunan Xiangjiang Liyuan Jiankun Entrepreneurship Investment Partnership (Limited Partnership) [1] - The shares to be reduced were acquired before the company's initial public offering and have been tradable since December 26, 2023 [1] Group 2 - Mountain Outside Mountain was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on December 26, 2022, with an issuance of 36.19 million shares at a price of 32.30 yuan per share, currently trading below the issue price [2] - The total amount raised from the initial public offering was 1.1689370 billion yuan, with a net amount of 1.0671109 billion yuan after deducting issuance costs, which was 179.6284 million yuan less than the planned amount [2] - The funds raised are intended for projects related to blood purification equipment, research and development centers, marketing network upgrades, and working capital [2] Group 3 - On July 2, 2024, Mountain Outside Mountain announced a cash dividend of 0.20 yuan per share and a capital reserve increase of 0.49 shares per share, resulting in a total distribution of 43,129,617 yuan in cash and 105,667,561 shares, increasing the total share capital to 321,315,646 shares [3] - The record date for this distribution is July 8, 2024, and the ex-dividend date is July 9, 2024 [3] - Previously, on September 28, 2023, the company announced a similar distribution based on a total share capital of 144,730,259 shares, with a cash dividend of 0.20 yuan per share and a capital reserve increase of 0.49 shares per share, totaling 28,946,051.80 yuan in cash and 70,917,826 shares [3]

山外山首次公开发行股票募集资金总额116,893.70万元，扣除发行费用后，募集资金净额为106,711.09万 元。山外山最终募集资金净额比原计划少17,962.84万元。山外山于2022年12月21日披露的招股说明书显 示，该公司拟募集资金124,673.93万元，分别用于血液净化设备及高值耗材产业化项目、血液净化研发 中心建设项目、营销网络升级与远程运维服务平台建设项目、补充流动资金。 中国经济网北京4月16日讯山外山(688410.SH)今日收报11.05元，跌幅3.83%。目前该股处于破发状态。 山外山保荐机构(主承销商)为西部证券（002673）股份有限公司，保荐代表人为邹扬、李锋，联席主承 销商为国海证券股份有限公司。山外山首次公开发行股票的发行费用总计为10,182.61万元(不含增值 税)，其中保荐承销费7,513.62万元(不含增值税)。 山外山于2022年12月26日在上交所科创板上市，发行股票数量为3,619万股，发行价格为32.30元/股。 2024年7月2日，山外山披露《2023年年度权益分派实施公告》，以方案实施前的公司总股本215,648,085 股为基数，每股派发现金红利0. ...